Overview on a group level, and let me start with sales. So overall, we reported a 12% sales growth on a group level and achieved 888 million sales. If we exclude the unfavorable currency impact, the growth would have been 13%. But there are three key elements which I would like to call out to give a bit of a color behind our sales performance. Gavin already mentioned Easter. So during holiday seasons, it's very typical for us to see a lower order intake. We experience this every time in the Christmas period, every year. That's the usual thing. And this year, because Easter was in March in 2023. In 2023, Easter was in April. And now this year in March. We have to take a better look here at the April performance. We already have the preliminary sales numbers available and, looking at those, year to date, April sales performance is already at 17%. So we can see the correction in the April months. Then the second important element to highlight here is the contribution, the sustained contribution of our growth markets. We can see that those segments are contributing solidly to our overall growth. However, this quarter, the core markets' contribution was lower than historically. And here comes the third part, which Gavin already mentioned: the decline in the small segment. If we look at our sales drivers, net sales drivers, then the nicotine pouch remains solid. However, the smooth decline weighed heavily into our overall growth. With this, let me move to the profitability, because here I think we achieved a major step towards our long-term commitment of the targets we set down on our capital markets day. So our gross margin for the quarter increased by 2.4%. This increase is predominantly driven by the annual commercial renegotiations. And typically such change happens only from Q4 to Q1 and throughout the year it's relatively stable. The margin improvement Was partly reinvested into overheads, into new capabilities and capacity. Particularly behind the new emerging market segment. And overall, this resulted in an adjusted EBIT of 3.5%, an increase of 1.2% from 2.3% in Q1 2023. Important to highlight here that the core and growth markets' EBITDA was at 6.1%, 0.8% out of which was invested into the emerging markets. So the total group EBITDA was at 5.6%. With the depreciation results in the 3.5% adjusted EBIT. I would like to also highlight the cash flow performance from operating activities, because we achieved 122 million SEK positive cash flow. This is a combination of better lower inventory levels after year end, but also mainly driven by improved trading terms with our suppliers for the payables. We reported some exceptional costs in this quarter, and these are connected to the impairment of the retired equipment for the Stockholm warehouse, where in previous years we overhauled the entire infrastructure to improve capacity. Moving to the core markets here. The net sales increased by 2% in Q1. In constant currency, the increase was 3%. Again, year to date. April is an important figure here to bear in mind because that increase is already at an 8% level. We are happy with our nicotine sales performance, which remains strong and grew 32% in the quarter and 34% year to date. April. Based on our understanding, this growth is ahead of the market growth. So indicates that we are gaining share. This new performance, which occurred over the weekend in Q1. It has to be seen also from a long-term perspective. We do not see the category as part of our long-term strategy. There are not enough innovative products coming through from the suppliers, and there is a very low level of appetite to invest in the category by the brand owners, whose focus is clearly shifted towards nicotine pouches. However, we recognize that this new category is not going to disappear. Completely. So we took actions to mitigate this decline, as Gavin already indicated. The adjusted EBITDA grew 6.5% to almost 54 million, reaching 8.6%, up by 0.4 versus last year. This is mainly attributable to a favorable mix impact within the categories. Moving to the growth market. Let me start with the sales, which increased by 46%. Here we saw strong performance across all markets, but especially in the US. Nicotine pouches grew by 59% in the US. I would like to highlight California and the impact of California because, as we talked about a year ago when we announced the Q1 report, we highlighted that due to the flavor ban, Haypp Group also benefited greatly from the increased consumer demand for products which were legally available by online retailers. However, we see that since then many consumers reverted back to using flavored nicotine pouches, which created a temporary headwind for Q1 for us. And this is what we evidently see in our sales in California. However, outside of California, we achieved a 70% growth overall. EBIT is another important element and a great milestone that we reached in the growth market. This quarter, from being a clear profit for the group. This quarter we resulted around the breakeven result, very slight positive adjusted EBITDA, which is clearly driven by economies of scale, very partly offset by commercial investment. And obviously, there is a key role here for the annual commercial negotiations, which have improved our overall margin performance in this market segment. Last but not least, emerging markets here. Financially speaking, there is not too much to say. These categories are in their infancy. So as you can see, we achieved an 8 million SEK in sales. And overall, we invested 7 million on a level, these 7 million investments mainly went into capacity and capability in specific parts of the organization, mainly in commercial search optimization and category management. At this stage, I believe that the success of this category is not to be seen through the financial KPIs, but more on how we can build our positioning and progress in terms of customer acquisition. Within this segment. Let me move to the selected KPIs. I already told you about a strong cash flow performance and strong EBITDA. What we had. The combination of these two is resulting in a nice decrease in our net debt to adjusted EBITDA ratio, which is down to 0.8%. As I look ahead, I believe that our business model will allow us to maintain the capital-lite structure. And maintain our healthy balance sheet so we are ready for the next phase of growth. With that, I give it back to you, Gavin. Thank you.